The effect of Medicago Sativa plant on anemia

The effect of oral intake of Medicago Sativa plant leaf on blood factors related to anemia

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201408317803N2

Enrollment

Registered

2015-02-02

Start date

2014-11-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anemia. Iron deficiency anaemia

Interventions

Intervention 1: 500 miligram oral capsules should be taken twice a day for a period of one month. Intervention 2: 500 miligram starch oral capsules should be taken twice a day for a period of one mont

Treatment - Drugs

Placebo

500 miligram oral capsules should be taken twice a day for a period of one month

500 miligram starch oral capsules should be taken twice a day for a period of one month

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Inclusion criteria: Mature healthy person Exclusion criteria: Failure to use capsules

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Hb. Timepoint: Blood sampling from test subjects, before taking capsules then two and four weeks after that. Method of measurement: analysis of blood samples.;Hct. Timepoint: Blood sampling from test subjects, before taking capsules then two and four weeks after that. Method of measurement: analysis of blood samples.;MCV. Timepoint: Blood sampling from test subjects, before taking capsules then two and four weeks after that. Method of measurement: analysis of blood samples.;MCH. Timepoint: Blood sampling from test subjects, before taking capsules then two and four weeks after that. Method of measurement: analysis of blood samples.;MCHC. Timepoint: Blood sampling from test subjects, before taking capsules then two and four weeks after that. Method of measurement: analysis of blood samples.	—

Measure

Time frame

Hb. Timepoint: Blood sampling from test subjects, before taking capsules then two and four weeks after that. Method of measurement: analysis of blood samples.;Hct. Timepoint: Blood sampling from test subjects, before taking capsules then two and four weeks after that. Method of measurement: analysis of blood samples.;MCV. Timepoint: Blood sampling from test subjects, before taking capsules then two and four weeks after that. Method of measurement: analysis of blood samples.;MCH. Timepoint: Blood sampling from test subjects, before taking capsules then two and four weeks after that. Method of measurement: analysis of blood samples.;MCHC. Timepoint: Blood sampling from test subjects, before taking capsules then two and four weeks after that. Method of measurement: analysis of blood samples.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFaraz Mojab

Shahid Beheshti University of Medical Sciences

sfmojab@yahoo.com/ fatemehagaah@gmail.com+98 21 8820 0120

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026